Holen Sie sich die Stockscreener-App
397.97
1.28%
-5.14
Vorhandelsmarkt:
397.45
-0.52
-0.13%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt UTHR?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$403.11
Offen:
$403.09
24-Stunden-Volumen:
485.49K
Relative Volume:
0.73
Marktkapitalisierung:
$17.95B
Einnahmen:
$2.99B
Nettoeinkommen (Verlust:
$1.21B
KGV:
15.88
EPS:
25.06
Netto-Cashflow:
$1.13B
1W Leistung:
-1.44%
1M Leistung:
+27.09%
6M Leistung:
+29.53%
1J Leistung:
+15.36%
1-Tages-Spanne:
$397.00
$404.42
1-Wochen-Bereich:
$395.00
$407.06
52-Wochen-Spanne:
$266.98
$436.95
United Therapeutics Corp Stock (UTHR) Company Profile
Firmenname
United Therapeutics Corp
Sektor
Telefon
(301) 608-9292
Adresse
1000 SPRING ST, SILVER SPRING, MD
Vergleichen Sie UTHR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
UTHR
United Therapeutics Corp
|
397.97 | 18.23B | 2.99B | 1.21B | 1.13B | 25.06 |
|
ZTS
Zoetis Inc
|
147.46 | 64.82B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.12 | 47.56B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.28 | 43.31B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.68 | 21.67B | 16.70B | -157.13M | 1.19B | -0.155 |
United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-04-21 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-07-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-02-12 | Hochstufung | Goldman | Sell → Neutral |
| 2024-02-05 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2022-12-06 | Eingeleitet | UBS | Buy |
| 2022-12-05 | Eingeleitet | Goldman | Sell |
| 2022-10-11 | Eingeleitet | Morgan Stanley | Overweight |
| 2022-09-20 | Bestätigt | BofA Securities | Underperform |
| 2022-09-19 | Fortgesetzt | Wedbush | Outperform |
| 2022-02-11 | Eingeleitet | BTIG Research | Neutral |
| 2021-07-14 | Hochstufung | Argus | Hold → Buy |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-02-01 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-09-14 | Fortgesetzt | JP Morgan | Overweight |
| 2020-06-25 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-03-10 | Hochstufung | Jefferies | Hold → Buy |
| 2020-02-27 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-01-31 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-12-03 | Eingeleitet | BofA/Merrill | Underperform |
| 2019-08-01 | Hochstufung | Jefferies | Underperform → Hold |
| 2019-08-01 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2019-07-01 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-05-17 | Hochstufung | UBS | Sell → Neutral |
| 2019-05-09 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2018-10-12 | Hochstufung | Standpoint Research | Hold → Buy |
| 2018-08-08 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2018-04-03 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2018-02-22 | Bestätigt | Barclays | Underweight |
| 2018-01-18 | Fortgesetzt | Credit Suisse | Underperform |
| 2017-12-27 | Bestätigt | Wedbush | Outperform |
| 2017-04-27 | Bestätigt | Wedbush | Outperform |
| 2017-03-30 | Eingeleitet | UBS | Sell |
| 2017-03-16 | Eingeleitet | Credit Suisse | Underperform |
Alle ansehen
United Therapeutics Corp Aktie (UTHR) Neueste Nachrichten
United Therapeutics president sells shares worth $3.7 million - MSN
Buybacks Report: Is United Therapeutics Corporation affected by consumer sentimentRisk Management & Verified Entry Point Detection - خودرو بانک
United Therapeutics Corporation $UTHR Shares Acquired by Ashton Thomas Private Wealth LLC - MarketBeat
United Therapeutics Corporation $UTHR Holdings Lifted by Acadian Asset Management LLC - MarketBeat
Fred Alger Management LLC Takes Position in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics (NASDAQ:UTHR) Director Jan Malcolm Sells 700 Shares - MarketBeat
United Therapeutics (NASDAQ:UTHR) COO Michael Benkowitz Sells 5,000 Shares - MarketBeat
Insider Selling: United Therapeutics (NASDAQ:UTHR) COO Sells 11,375 Shares of Stock - MarketBeat
Growth Value: What is United Therapeutics Corporation’s valuation compared to sectorRisk Management & Stepwise Swing Trade Plans - خودرو بانک
Swedbank AB Lowers Position in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics (NASDAQ:UTHR) Price Target Raised to $525.00 at Cantor Fitzgerald - MarketBeat
Axiom Investors LLC DE Has $500,000 Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat
Integrated Wealth Concepts LLC Sells 7,962 Shares of United Therapeutics Corporation $UTHR - MarketBeat
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Purchases 25,289 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Jacobs Levy Equity Management Inc. Grows Stake in United Therapeutics Corporation $UTHR - MarketBeat
Inspire Investing LLC Sells 1,237 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Royal Bank of Canada Purchases 32,867 Shares of United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics Corporation $UTHR Shares Sold by Integrated Wealth Concepts LLC - Defense World
Advisors Asset Management Inc. Boosts Stake in United Therapeutics Corporation $UTHR - MarketBeat
Insider Selling: United Therapeutics (NASDAQ:UTHR) Director Sells 4,560 Shares of Stock - MarketBeat
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 8,000 Shares - MarketBeat
Talon Private Wealth LLC Grows Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat
21,112 Shares in United Therapeutics Corporation $UTHR Acquired by Capital Impact Advisors LLC - MarketBeat
Major IPF Treatment Breakthrough: United Therapeutics Reveals TETON-2 Trial Results at European Congress - Stock Titan
Cantor Fitzgerald Forecasts Strong Price Appreciation for United Therapeutics (NASDAQ:UTHR) Stock - Defense World
Equities Analysts Issue Forecasts for UTHR FY2026 Earnings - Defense World
Amundi Has $107.64 Million Stake in United Therapeutics Corporation $UTHR - MarketBeat
Federation des caisses Desjardins du Quebec Purchases 936 Shares of United Therapeutics Corporation $UTHR - MarketBeat
3 High-Growth Stocks Poised to Extend Gains Into Year-End - Investing.com
United Therapeutics stock maintains Buy rating at UBS on IPF opportunity - Investing.com Nigeria
United Therapeutics stock maintains Buy rating at UBS on IPF opportunity By Investing.com - Investing.com South Africa
Empowered Funds LLC Raises Stock Position in United Therapeutics Corporation $UTHR - MarketBeat
United Services Automobile Association Invests $876,000 in United Therapeutics Corporation $UTHR - MarketBeat
Dynamic Technology Lab Private Ltd Invests $867,000 in United Therapeutics Corporation $UTHR - MarketBeat
Clark Capital Management Group Inc. Has $29.09 Million Holdings in United Therapeutics Corporation $UTHR - MarketBeat
Hancock Whitney Corp Has $2.04 Million Position in United Therapeutics Corporation $UTHR - MarketBeat
Cantor Fitzgerald Raises Price Target for United Therapeutics (U - GuruFocus
United Therapeutics stock price target raised to $525 by Cantor Fitzgerald - Investing.com
United Therapeutics Corporation (NASDAQ:UTHR) Sees Significant Increase in Short Interest - MarketBeat
HC Wainwright Issues Positive Forecast for United Therapeutics (NASDAQ:UTHR) Stock Price - MarketBeat
United Therapeutics Corporation $UTHR Shares Sold by Alliancebernstein L.P. - MarketBeat
United Therapeutics Corporation $UTHR Stake Cut by Nitorum Capital L.P. - MarketBeat
Brokerages Set United Therapeutics Corporation (NASDAQ:UTHR) PT at $429.62 - MarketBeat
United Therapeutics (UTHR): Evaluating Valuation After Breakthrough IPF Trial Results Drive Analyst Upgrades - simplywall.st
RSI Suggests Rebound May Be Near in United Therapeutics CorporationCEO Change & Reliable Entry Point Trade Alerts - beatles.ru
Parkman Healthcare Partners LLC Decreases Stake in United Therapeutics Corporation $UTHR - MarketBeat
Does United Therapeutics Corporation have declining or rising EPSTrade Entry Report & Stepwise Trade Signal Guides - beatles.ru
United Therapeutics (NASDAQ:UTHR) Trading Down 4.8% Following Insider Selling - MarketBeat
Wayfair, United Therapeutics, And Ciena Are Among The Top 10 Large-Cap Gainers Last Week (July 14-July 18): Are The Others In Your Portfolio? - Benzinga
MPM Bioimpact LLC Boosts Position in United Therapeutics Corporation $UTHR - MarketBeat
Finanzdaten der United Therapeutics Corp-Aktie (UTHR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.11%
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):